FDA.reportPublic FDA data

4 ML bevacizumab 25 MG/ML Injection

RxCUI
1657066
RxNorm name
4 ML bevacizumab 25 MG/ML Injection
Display name
4 ML bevacizumab 25 MG/ML Injection
Full name
4 ML bevacizumab 25 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125085Avastinbevacizumab351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AvastinBEVACIZUMABGenentech, Inc.939b5d1f-9fb2-4499-80ef-0607aa6b114e2025-01-06Warnings, Adverse reactionsExact identifier
rxcui: 1657066

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
939b5d1f-9fb2-4499-80ef-0607aa6b114ebevacizumab 100 MG in 4 ML Injection [PSN] · 4 ML bevacizumab 25 MG/ML Injection [SCD] · bevacizumab 100 MG per 4 ML Injection [SY]339These highlights do not include all the information needed to use AVASTIN safely and effectively. See full prescribing information for AVASTIN. AVASTIN ® (bevacizumab) injection, for intravenous use Initial U.S. Approval: 200420250106